The White House is exploring a pre-release vetting process for AI models - meaning companies could need government sign-off before launching new systems to the public. No formal framework has been announced, but the consideration alone signals that the current approach of voluntary safety commitments may not hold.
Right now, labs like OpenAI, Anthropic, and Google ship models on their own timelines with self-reported safety testing. A mandatory pre-release review would fundamentally change that. Think of it like a pharmaceutical approval process: the FDA doesn't let drug companies self-certify efficacy. The White House appears to be asking whether AI warrants similar oversight.
What a Vetting Process Would Actually Mean
The practical questions are enormous. Who does the vetting - a new agency, NIST, the NSA? What criteria disqualify a model? How long does review take? A two-week review window is trivial for a government body but catastrophic for a lab in a competitive race. A six-month window essentially halts commercial AI development as we know it.
For daily users of tools like ChatGPT or Claude, the direct impact would be delayed access to new capabilities. If GPT-5 or Claude 4 had needed government clearance before shipping, both would likely still be in review queues.
The policy debate isn't really about safety versus innovation - it's about who decides what's safe. Labs argue they have the most context on their own systems. Policymakers counter that self-policing has obvious limits. Both are right, which is why any workable framework will require the government to build genuine technical capacity rather than outsourcing judgment back to the companies being regulated.
No timeline for a decision has been reported. Given the current administration's stated priority of maintaining US AI competitiveness, a heavy-handed mandatory approval process seems unlikely - but some form of pre-release disclosure requirement is increasingly on the table.